E. Schlicht

发表

Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers

Raymond M. Moore, Zhifu Sun, K. Lazaridis, 2021, BMC Gastroenterology.

Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T‐lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction

K. Siminovitch, J. Larson, E. Atkinson, 2010, Hepatology.

Reduced coffee consumption among individuals with primary sclerosing cholangitis but not primary biliary cirrhosis.

M. de Andrade, E. Atkinson, C. Lammert, 2014, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Feasibility of a large multi-center translational research project for newly diagnosed breast and ovarian cancer patients with affiliated biobank: the BRandO biology and outcome (BiO)-project

A. Rempen, G. Nagel, D. Rothenbacher, 2019, Archives of Gynecology and Obstetrics.

DNA methylation profile of liver tissue in end-stage cholestatic liver disease

Raymond M. Moore, G. Gores, N. LaRusso, 2022, Epigenomics.

Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease

Mariza de Andrade, Andre Franke, Wolfgang Lieb, 2016, Nature Genetics.

Bile Acid Profiles in Primary Sclerosing Cholangitis and Their Ability to Predict Hepatic Decompensation

G. Gores, T. Karlsen, Chang Hu, 2020, Hepatology.

A comprehensive assessment of environmental exposures among 1000 North American patients with primary sclerosing cholangitis, with and without inflammatory bowel disease

N. Chalasani, E. Atkinson, M. Andrade, 2015, Alimentary pharmacology & therapeutics.

Liquid Biopsy in Cholestatic Liver Disease Using Hepatocyte-Specific Methylation Markers

Raymond M. Moore, K. Lazaridis, B. Juran, 2021 .

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways

Casey S. Greene, Marco Carbone, Andrew Fraser, 2015, Nature Communications.

Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants.

P. Gregersen, K. Siminovitch, C. Amos, 2012, Human molecular genetics.

Questionnaire based assessment of risk factors for primary biliary cirrhosis.

J. Larson, E. Atkinson, C. Lammert, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

High‐Resolution Exposomics and Metabolomics Reveals Specific Associations in Cholestatic Liver Diseases

Dean P. Jones, Megan M. Niedzwiecki, G. Gores, 2021, Hepatology communications.

Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis

A. Athreya, G. Gores, T. Karlsen, 2023, Exposome.

Primary biliary cirrhosis is associated with a genetic variant in the 3' flanking region of the CTLA4 gene.

B. Fridley, E. Atkinson, K. Lazaridis, 2008, Gastroenterology.

Common Genetic Variation and Haplotypes of the Anion Exchanger SLC4A2 in Primary Biliary Cirrhosis

J. Larson, E. Atkinson, K. Lazaridis, 2009, The American Journal of Gastroenterology.

Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T‐lymphocyte antigen 4 and programmed cell‐death 1 influence risk and features of primary biliary cirrhosis

B. Fridley, G. Petersen, E. Atkinson, 2007, Hepatology.

Genetic polymorphisms of matrix metalloproteinase 3 in primary sclerosing cholangitis

A. Franke, J. Larson, D. Ellinghaus, 2011, Liver international : official journal of the International Association for the Study of the Liver.

External validation of the United Kingdom‐primary biliary cholangitis risk scores of patients with primary biliary cholangitis treated with ursodeoxycholic acid

M. de Andrade, E. Atkinson, K. Lazaridis, 2018, Hepatology communications.

Biochemical response to ursodeoxycholic acid predicts survival in a North American cohort of primary biliary cirrhosis patients

E. Atkinson, M. Andrade, L. Chan, 2014, Journal of Gastroenterology.

Low incidence of primary biliary cirrhosis (PBC) in the first‐degree relatives of PBC probands after 8 years of follow‐up

E. Atkinson, K. Lazaridis, B. Juran, 2016, Liver international : official journal of the International Association for the Study of the Liver.

Primary Sclerosing Cholangitis Risk Estimate Tool (PREsTo) Predicts Outcomes of the Disease: A Derivation and Validation Study Using Machine Learning

G. Gores, T. Karlsen, N. LaRusso, 2020, Hepatology.

Variations in primary sclerosing cholangitis across the age spectrum

E. Atkinson, M. Andrade, K. Lazaridis, 2017, Journal of gastroenterology and hepatology.

The PSC scientific community resource: an asset for multi-omics interrogation of primary sclerosing cholangitis

E. Atkinson, K. Lazaridis, B. Juran, 2021, BMC Gastroenterology.

Carriage of a tumor necrosis factor polymorphism amplifies the cytotoxic T‐lymphocyte antigen 4 attributed risk of primary biliary cirrhosis: Evidence for a gene–gene interaction

K. Siminovitch, J. Larson, E. Atkinson, 2010, Hepatology.